Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06655714
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-10-22
Brief Title:
Evaluation of Inadequate Response to Ultrasound-Guided Subacromial Corticosteroid Injection in Shoulder Impingement Syndrome
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Evaluation of Inadequate Response to Ultrasound-Guided Subacromial Corticosteroid Injection in Shoulder Impingement Syndrome Treatment Failure or Central Sensitization
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to investigate the impact of central sensitization in patients with shoulder impingement syndrome who have shown an inadequate response to ultrasound-guided subacromial corticosteroid injection Additionally the patients pain perception and emotional state will be evaluated and the relationships between these factors and the treatment response will be analyzed
Detailed Description:
Seventy-two patients aged 18-65 who applied to the Physical Therapy and Rehabilitation outpatient clinic at Beylikdüzü State Hospital diagnosed with shoulder impingement syndrome based on magnetic resonance imaging MRI and who received ultrasound-guided corticosteroid injection will be included in the study No additional interventions or procedures will be performed for the research These patients who were previously assessed and treated in the outpatient clinic will be invited for a follow-up examination at the 4th week after the injection During the follow-up their response to the treatment will be evaluated using the Visual Analog Scale VAS A reduction of less than 50 on the VAS by the end of the 4th week will be considered an inadequate response Patients with inadequate and good responses will be divided into two groups and assessed for central sensitization pain perception and emotional state Central sensitization will be evaluated using the Central Sensitization Inventory CSI and hyperalgesia will be assessed using an algometer to measure pressure-pain threshold Additionally the Pain Catastrophizing Scale and the Hospital Anxiety and Depression Scale will be used to determine the patients emotional state and pain perception
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None